Psychosocial Intervention App Feasible in Serious Mental Illness

This article originally appeared here.
Share this content:
Psychosocial Intervention App Feasible in Serious Mental Illness
Psychosocial Intervention App Feasible in Serious Mental Illness

FRIDAY, Aug. 18, 2017 (HealthDay News) -- A psychosocial self-management intervention can be adapted for smartphone application and used by adults with serious mental illness, according to a study published in the August issue of the American Journal of Geriatric Psychiatry.

Karen L. Whiteman, Ph.D., from the Dartmouth Centers for Health and Aging in Lebanon, N.H., and colleagues examined the technical abilities and needs of middle-aged and older adults with serious mental illnesses using smartphones. Through principles of user-centered design, the authors developed smartphone content and modified an existing smartphone platform. A usability test was conducted using think aloud and verbal probing.

The researchers tested the usability of a psychosocial self-management intervention adapted to a smartphone application. A high level of usability and satisfaction with the smartphone application was reported by 10 participants (mean age, 55.3 years) with serious mental illness and comorbid chronic health conditions.

"Middle-aged and older adults with serious mental illness and limited technical abilities were able to participate in a process involving user-centered design and adaptation of a self-management intervention to be delivered by a smartphone," the authors write. "Future research is indicated to establish effectiveness and to determine the type and intensity of clinical support needed to successfully implement smartphone applications as a component of community-based services for older adults with psychiatric and medical conditions."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »